➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Johnson and Johnson
AstraZeneca
Harvard Business School
Colorcon

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

FOLLISTIM Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: FOLLISTIM
Patents:9
Applicants:1
BLAs:3
Drug Prices: Drug price information for FOLLISTIM
Recent Clinical Trials: See clinical trials for FOLLISTIM
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for FOLLISTIM
Drug Prices for FOLLISTIM

See drug prices for FOLLISTIM

Recent Clinical Trials for FOLLISTIM

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Ferring PharmaceuticalsPhase 2
Center for Human ReproductionPhase 1/Phase 2
Michigan Reproductive MedicinePhase 4

See all FOLLISTIM clinical trials

Recent Litigation for FOLLISTIM

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Serono, Inc. v. Industria Pharmaceuticals, Inc.2004-02-13
Sereno, Inc. v. Ferring2002-09-18

See all FOLLISTIM litigation

Company Disclosures: US Patents for FOLLISTIM

These patents were extracted from company disclosures
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Genzyme Corporation (Cambridge, MA) 2015-06-16 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Akzo Nobel, N.V. (Arnhem, NL) 2017-01-15 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Ares Trading S.A. (Aubonne, CH) 2018-07-23 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 001 2004-03-23   Start Trial Ares Trading S.A. (Aubonne, CH) 2018-07-23 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 002 2004-03-23   Start Trial Genzyme Corporation (Cambridge, MA) 2015-06-16 DISCN company
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211 002 2004-03-23   Start Trial Akzo Nobel, N.V. (Arnhem, NL) 2017-01-15 DISCN company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Start Trial

Patent Text Search: US Patents for FOLLISTIM

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582 001 1998-11-18   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 DISCN search
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582 001 1998-11-18   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 DISCN search
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582 001 1998-11-18   Start Trial Amylin Pharmaceuticals, Inc. (San Diego, CA) 2022-01-22 DISCN search
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582 001 1998-11-18   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 DISCN search
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582 001 1998-11-18   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 DISCN search
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582 002 1998-11-18   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKinsey
Dow
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group

DrugPatentWatch reviews